| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 2.71 MB | Adobe PDF |
Advisor(s)
Abstract(s)
During wound healing, an early inflammation can cause an increase of the wound size and the healing process can be considerably belated if a disproportionate inflammatory response occurs. (S)-ibuprofen (IBP), a non-steroidal anti-inflammatory agent, has been used for muscle healing and to treat venous leg ulcers, but its effect in skin wound healing has not been thoroughly studied thus far. Herein, IBP-β-cyclodextrins carriers were designed to customise the release profile of IBP from poly(vinyl alcohol)/chitosan (PVA/CS) dressings in order to promote a faster skin regeneration. The dressings were produced using supercritical carbon dioxide (scCO2)-assisted technique. In vitro IBP release studies showed that β-cyclodextrins allowed a controlled drug release from the hydrogels which is crucial for their application in wound management. Moreover, the in vivo assays revealed that the presence of PVA/CS membranes containing IBP-β-cyclodextrins carriers avoided scab formation and an excessive inflammation, enabling an earlier skin healing.
Description
Keywords
Drug delivery systems Composite membranes Wound dressings Ibuprofen In vivo assays Supercritical carbon dioxide
Citation
Morgado, P. I., Miguel, S. P., Correia, I. J., Aguiar-Ricardo, A. (2017) “Ibuprofen loaded PVA/Chitosan membranes: a highly efficient strategy towards an improved skin wound healing.” Carbohydrate Polymers, Vol.159, pp.136-145
Publisher
Elsevier